Incannex Healthcare (IXHL)

• Market cap: $4.05M
• 1 day: -75.92%
• 5 days: -75.60%
• 1 month: -78.29%
• 3 months: -91.15%
• 6 months: -93.38%
• Year to date: -92.73%
• 1 year: -94.17%
• 5 years: -99.01%
• 10 years: -99.01%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Employees: 9

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

0.6% less ownership

Funds ownership: 2.51% [Q3] → 1.91% (-0.6%) [Q4]

19% less capital invested

Capital invested by funds: $880K [Q3] → $714K (-$166K) [Q4]

42% less funds holding

Funds holding: 12 [Q3] → 7 (-5) [Q4]

83% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 6